CDRH Director Shuren to step down after 15 years
Michelle Tarver, deputy director for transformation, will serve as acting director of the FDA’s medical devices unit.
Jeff Shuren, who leads the Food and Drug Administration’s medical devices unit, will step down after 15 years as director.
Michelle Tarver, deputy director for transformation at the Center for Devices and Radiological Health, will become acting director of the group effective July 28, according to an email Tuesday from FDA Commissioner Robert Califf to staff, which an agency spokesperson shared with MedTech Dive.
Shuren, who is retiring from the FDA, will assist in the transition before leaving the agency later this year. The FDA will conduct a nationwide search for a permanent successor.
In a farewell message to agency colleagues, Shuren said the timing was right to step back this summer, before preparations begin for the next reauthorization of the Medical Device User Fee Amendments, and after the agency issued its final rule on laboratory developed tests.
“I have been here as the Center Director for a generation. That is a long time,” Shuren wrote. “I have been asked many times over the years ‘Why do you stay?’ Our...
